Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOCT.L Regulatory News (OCT)

  • There is currently no data for OCT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update for Trading Subsidiary

1 May 2019 07:00

RNS Number : 6446X
Octagonal PLC
01 May 2019
 

For immediate release

1 May 2019

 

Octagonal plc

("Octagonal" or the "Company")

Trading Update for Trading Subsidiary

 

 

Following completion of the reporting period to 31 March 2019, Octagonal provides the following trading update for its principal and wholly owned trading subsidiary - Global Investment Strategy UK Limited ("GIS").

 

The Board is pleased to announce that GIS expects to report EBITDA of £1.77million, on sales of £5.4 million for the year ended 31 March 2019. Although this is a 41.2% decrease in profits (2018: £3.01 million) and 17.6% decrease in sales (2018: £6.53 million) from the previous year, these results reflect the reduction of £0.8m in non-core Corporate finance income reported in 2018. We further experienced challenging geopolitical uncertainties in the current market that impacted volatility and market volumes.

 

As a highlight and included within our longer-term business plan, GIS has incurred costs associated with the regulatory governance of the SynerGis business brand in key areas of oversight, IT infrastructure, and mandatory control. This increased level of commitment is commensurate with our future growth expectations that are seen as integral in supporting the long term strategy in all areas of the business. These benefits have been embedded within our future business plan and are expected to be downstream. More immediately the Board will maintain focus on improving efficiencies and reducing transaction costs as well as offering a broader range of services to clients.

 

Highlights

 

 

· Cash in the bank or equivalents as at 31 March 2019 was more than £5.4m

· Sales decreased 17.6% against FY2018

· EBITDA reduced by 41.2% against FY2018 - the majority owing to a reduction in non-core Corporate Finance income and impact of geopolitical events on world markets.

· Net profit margins 33%

· Grant of SFC approval for wholly owned subsidiary to carry out Type 1 regulated activity in Hong Kong.

· Further progress towards launch of the SynerGis Bond

· Financial Services Compensation Scheme (FSCS) for eligible claimants has increased from £50,000 to £85,000 as of 1st April 2019 providing increased protection to SynerGIS bondholders.

 

 

The Group's audited results will be announced in due course.

 

 

John Gunn CEO commented;

 

"The first half of the year saw sales and earnings come in-line with expectations, as detailed in the interim statement, with the second half of the financial year presenting many challenges. 

Political deadlock and shut down in Washington during our 3rd quarter coupled with the domestic concerns over Brexit have undoubtedly had its impact on equity and bond markets both domestically and overseas. 

 

We don't believe that either of these events represent a trend and are therefore not unduly concerned. The business continues to deliver meaningful returns and is focused on expanding the franchise. We are not immune from the volatility and lower volumes, but we must not allow the short-term turmoil to impact our strategy of developing a global diversified financial services group.

 

We were naturally pleased with the outcome of our application to the Securities and Futures Commission in Hong Kong for permission to conduct regulatory activity. We are currently undertaking a further review of this opportunity and we have recently moved to a new office location in the Central District of Hong Kong. The businesses tri-lingual website (www.gishkltd.com) has been launched and operations will commence shortly once the system implementations have been satisfied and further personnel recruited. We anticipate this will be in the month of May or early June. GIS has invested approximately £190,000 towards setting up and obtaining Hong Kong regulatory approvals during the reporting period. These costs have been capitalised until the Hong Kong/Asia-Pac trading activity commences.

 

Discussions continue with the FCA as regards SynerGis activity. 

The business is undergoing an evaluation process with our regulator and we believe we've made good progress in demonstrating the businesses robust processes and controls that are essential for intended specialist lending activity. 

We believe that these discussions are nearing their conclusion and we'll shortly be in a position to update you further.

 

On a very positive point and following a long-term consultation open to all regulated financial firms, the FCA and Financial Services Compensation Scheme (FSCS) announced an update to their compensation limits on 1st April 2019. Effective immediately, the compensation limit for eligible claimants has risen from £50,000 to £85,000. This brings the level of FSCS compensation for investment products in line with that of bank and savings accounts at £85,000.

 

During the reporting period, GIS invested a further £200,000 in Synergis Capital Plc and the effective shareholding holding at the year end was approximately 77%".

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information please visit www.octagonalplc.com or contact:

 

Octagonal Plc

+44 (0) 20 7048 9400

John Gunn, CEO

Beaumont Cornish Limited (Nominated Adviser and Broker)

James Biddle / Roland Cornish

+44 (0) 20 7628 3396

www.beaumontcornish.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTURSNRKWASOAR
Date   Source Headline
21st Jan 20217:00 amRNSCancellation - Octagonal plc
13th Jan 20211:15 pmRNSResult of AGM and Corporate Update
13th Jan 20217:00 amRNSHalf-year Report
11th Jan 20217:00 amRNSTrading and General Update
24th Dec 20201:04 pmRNSStatement re Suspension
24th Dec 20208:01 amRNSSuspension - Octagonal plc
21st Dec 20209:05 amRNSSecond Price Monitoring Extn
21st Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20204:40 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
17th Dec 20203:54 pmRNSPosting of Circular and Notice of AGM
17th Dec 20207:00 amRNSFinal Results
9th Dec 202011:38 amRNSUpdate re audited Accounts and Interim Dividends
11th Nov 202011:05 amRNSSecond Price Monitoring Extn
11th Nov 202011:00 amRNSPrice Monitoring Extension
11th Nov 20209:00 amRNSPrice Monitoring Extension
11th Nov 20207:00 amRNSTrading Update and Timing Update for Accounts
30th Sep 202011:33 amRNSUpdate on Accounts publication and Trading Update
12th May 20207:00 amRNSTrading Update for Trading Subsidiary
16th Mar 20202:06 pmRNSSecond Price Monitoring Extn
16th Mar 20202:00 pmRNSPrice Monitoring Extension
13th Nov 20197:00 amRNSHalf-year Report
18th Oct 201911:51 amRNSResult of AGM
25th Sep 20193:25 pmRNSFinal Results, Dividend declared and Notice of AGM
10th May 201910:07 amRNSDirector/PDMR Shareholding
7th May 201910:39 amRNSDirector/PDMR Shareholding
1st May 20197:00 amRNSTrading Update for Trading Subsidiary
1st Mar 20197:00 amRNSGIS Hong Kong subsidiary Update
28th Feb 20197:00 amRNSAppointment to subsidiary company board
8th Jan 201912:19 pmRNSGIS Hong Kong subsidiary Update
8th Nov 20184:30 pmRNSHalf-year Report
25th Oct 201811:53 amRNSResult of AGM
8th Oct 201812:53 pmRNSIssue of Equity
28th Sep 20185:31 pmRNSFinal Results
26th Sep 20187:00 amRNSHolding(s) in Company
25th Sep 201811:17 amRNSBoard Update
11th Jun 20184:58 pmRNSDirector/PDMR Shareholding
26th Apr 20182:00 pmRNSPrice Monitoring Extension
26th Apr 20187:00 amRNSTrading Update for Trading Subsidiary
28th Mar 20187:00 amRNSBoard Appointment
15th Jan 20184:32 pmRNSBoard Change
19th Dec 20172:20 pmRNSDirector's Dealing
24th Nov 20177:00 amRNSHalf-year Report
21st Nov 20177:00 amRNSUpdate on New Business Initiative
7th Nov 20177:00 amRNSDividend Declaration
31st Oct 20177:00 amRNSConfirmation of Capital Reduction
20th Oct 20177:00 amRNSTrading Update
2nd Oct 20177:00 amRNSTotal Voting Rights
28th Sep 201711:59 amRNSGrant of Director Options, PDMR Dealings
27th Sep 20172:56 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.